Commercial Paper Issuance Slides Sharply In September Amidst Liquidity Crunch
Short term funds raised through commercial paper fell sharply in September, as liquidity, nervousness about the credit quality of non-bank lenders and higher rates kept issuers at bay.
Issuances of commercial paper, which had hit an all-time high of Rs 1.76 lakh crore in August 2018, fell to a mere Rs 20,855 crore in September, according to preliminary data compiled by Prime Database. The final data set is likely to be issued only by middle of October and could see a change in trend. The source of data collection is from arrangers of such issues and different from the commercial paper data provided by the RBI with a lag.
Commercial Paper (CP) is a debt instrument issued by companies to meet their short-term financing requirements from the money market. In the first quarter of the current financial year, CP issuances stood at Rs. 3.2 lakh crore, rising to Rs 4.92 lakh in the second quarter of the year.
In the fiscal year 2017-18, commercial paper issuance had hit a record high of Rs 12.55 lakh crore compared to Rs 10.66 lakh crore the previous year, shows data from Prime Database.
Tight liquidity in the system is the most significant reason for the decline, said R. Sivakumar, head of fixed income at Axis Mutual Fund. The recent spate of defaults by IL&FS further hurt issuances and trading of fixed income instruments, he told BloombergQuint.
To be sure, the issuance data at the end of the quarter is also brought down by higher redemptions. However, the past week to 10 days have seen especially slow activity in both the primary and secondary markets, he said. Sivakumar expects some upward revision in the figures by Prime database once the full data is compiled.
The rise in short-term rates in the month of September has also meant that borrowers can move towards bank borrowings.
While money market rates have risen, the Marginal Cost of Lending Rate (MCLR) by banks has not gone up by much, said Karthik Srinivasan, group head, financial sector ratings at ICRA. As a result, the difference between bank rates and CP rates have come down from near about 150 basis points earlier to about 50-75 basis points now enabling companies to diversify their liabilities, he explained.
In the first half of the financial year, borrowings via the bond market were proving to be cheaper and more abundant for corporations with good ratings. This was because some public sector banks were refraining from expanding their loan books. They were instead deploying their deposit surpluses in lower risk and capital light assets including call money market or reverse repo, stated an August report by ICRA on Commercial Paper activity. The turn in sentiment in September has led to a break in the trend, which may resume if market conditions stabilize.
Lower Trading Volumes
The tight-liquidity and the low-trust environment have hit the broader corporate bond segment as well, with trading volume in corporate bonds slipping on a month-on-month basis.
Corporate bond trading volume in the secondary markets has fallen by 16 percent in September 2018 from the previous month, shows data from Prime Database. This fall could be a combination of lower liquidity and unwillingness of investors to sell at a discount in the current environment of higher rates.
Analysts say that if liquidity conditions ease going forward due to the RBI's assurances and authorities are successful in curbing defaults emerging from the IL&FS group, trading and fresh issuances may pick up again.
Last week, the RBI further eased systemic liquidity conditions and said that system liquidity is in ample surplus. The government and the RBI have also met with shareholders at the IL&FS group, asking them to find a way to stem defaults.
Alert: This story has been modified to highlight the data source.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.